Stephen Andrew Welch is EVP & Head of Spec Generics of Mallinckrodt plc. Currently has a direct ownership of 0 shares of MNKPF, which is worth approximately $0. The most recent transaction as insider was on Nov 14, 2023, when has been sold 32,686 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Stephen Andrew Welch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2023
SELL
Sale (or disposition) back to the issuer
-
32,686 Reduced 100.0%
0 Ordinary Shares
Aug 17 2023
SELL
Payment of exercise price or tax liability
$4,042 $0.69 p/Share
5,859 Reduced 15.2%
32,686 Ordinary Shares
Mar 13 2023
BUY
Open market or private purchase
$8,480 $8.48 p/Share
1,000 Added 2.53%
38,545 Ordinary Shares
Dec 14 2022
BUY
Grant, award, or other acquisition
-
37,545 Added 50.0%
37,545 Ordinary Shares
SAW

Stephen Andrew Welch

EVP & Head of Spec Generics
Hazelwood, MO

Track Institutional and Insider Activities on MNKPF

Follow Mallinckrodt plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNKPF shares.

Notify only if

Insider Trading

Get notified when an Mallinckrodt PLC insider buys or sells MNKPF shares.

Notify only if

News

Receive news related to Mallinckrodt plc

Track Activities on MNKPF